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Abstract
Background: Single cell genomics (SCG) is a combination of methods whose goal is to decipher the complete genomic
sequence from a single cell and has been applied mostly to organisms with smaller genomes, such as bacteria and archaea.
Prior single cell studies showed that a significant portion of a genome could be obtained. However, breakages of genomic
DNA and amplification bias have made it very challenging to acquire a complete genome with single cells. We investigated
an artificial method to induce polyploidy in Bacillus subtilis ATCC 6633 by blocking cell division and have shown that we can
significantly improve the performance of genomic sequencing from a single cell.
Methodology/Principal Findings: We inhibited the bacterial cytoskeleton protein FtsZ in B. subtilis with an FtsZ-inhibiting
compound, PC190723, resulting in larger undivided single cells with multiple copies of its genome. qPCR assays of these
larger, sorted cells showed higher DNA content, have less amplification bias, and greater genomic recovery than untreated
cells.
Significance: The method presented here shows the potential to obtain a nearly complete genome sequence from a single
bacterial cell. With millions of uncultured bacterial species in nature, this method holds tremendous promise to provide
insight into the genomic novelty of yet-to-be discovered species, and given the temporary effects of artificial polyploidy
coupled with the ability to sort and distinguish differences in cell size and genomic DNA content, may allow recovery of
specific organisms in addition to their genomes.
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Introduction
Microbial communities are complex ’supra-organisms’ consist-
ing of bacteria, archaea, eukaryotes, and viruses that interact with
and depend upon one another in order to survive and thrive in
their natural environmental niches. In part due to the intrinsic
interdependencies within microbial communities, only a small
fraction (,1%) of all bacteria have been cultivated in isolation,
a pre-requisite for traditional genome sequencing efforts [1]. While
direct shotgun sequencing of environmental communities is
possible, assembly of metagenomic data into complete genomes
has thus far only been partly achieved for the simplest of microbial
communities [2,3]. Therefore novel approaches need to be devised
in order to isolate DNA from these ‘uncultured’ species in
sufficient quantities for genome sequencing, if we want to better
characterize the microbial world. One method becoming more
commonly used to address this problem is the technique of DNA
amplification of a single cell’s genome (known as single cell
genomics, or SCG) to provide adequate amounts of material for
sequencing protocols.
Roger S. Lasken [4] described an approach to SCG through
multiple displacement amplification (MDA) [5,6,7], which can
generate up to micrograms of DNA starting with as little as
femtograms present in a typical bacterium. MDA is based on
isothermal (30uC) strand displacement DNA synthesis in which the
highly processive w29 DNA polymerase repeatedly extends
random primers on the template as it concurrently displaces
previously synthesized copies and exposes single stranded DNA
that are used as new templates [8]. The ability to sequence from
single cells using amplified DNA was demonstrated by Raghu-
nathan et al. with flow sorted Eschericia coli, Myxococcus xanthus, and
Bacillus subtilis [7]. Whole genome sequencing with amplified DNA
has been tested on single cells of several target species such as
E. coli and Prochlorococcus [9], and has been used for novel de novo
sequencing of TM7 [10,11], flavobacteria [12,13], and Prochlor-
ococcus single cells [14]. These published efforts resulted in
fragmented genome assemblies with up to a thousand contigs or
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can reduce this to a much smaller number [13].
A fundamental problem of SCG as presently carried out lies in
the fact that only a single copy of genomic DNA serves as the
template. Consequently, if that single molecule of DNA is
fragmented with double stranded breaks (as can happen during
sample preparation), all linking information is lost resulting in
a genome sequence gap. When coupled with genome amplifica-
tion bias (a random bias thought to be introduced by initial
random priming events), as well as sequencing bias, the result is an
incomplete, fragmented genome. In this study, we sought to
overcome this major hurdle by inducing artificial polyploidy in
Figure 1. B. subtilis response to PC190723 treatment: Increased cell size. (A) Typical cytographs from treatments illustrate increase in cell size
in PC190723-treated B. subtilis versus untreated control and DMSO-treated cells at 60 minutes after treatment. Crosshairs were made at the mode of
the untreated control population and applied to the DMSO- and PC190723-treated cytographs. Resultant quadrants give the relative percentage of
the population (from 100,000 cells) inhabiting each quadrant. Thus, in quadrant two (Q2) of the control population, 44.7% of the cells are observed,
while over 80% are observed in the PC190723-treated population. DMSO has no effect on cell size. Percentages are calculated by omitting the lower
left population (A Control: black circle) from each cytograph, which likely contains dead cells and cell debris. (B) By determining DQ2 over time, cell
size is shown to plateau after 60 minutes. Error bars are 95% CI. (C) Typical light microscope images of sorted untreated control and PC190723-treated
cells. PC190723-treated cells are longer than untreated control cells, but the diameter appears unchanged.
doi:10.1371/journal.pone.0037387.g001
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the genome per single cell).
Our approach targets the critical cell division protein FtsZ in
such a fashion as to inhibit cell division while maintaining DNA
replication. FtsZ is a bacterial GTPase and homolog of
mammalian b-tubulin that polymerizes and assembles into a septal
ring typically at the middle of a dividing cell to initiate cell division.
FtsZ is conserved in almost all eubacterial species and in one
kingdom of archaea, Euryarchaeota, but not in Crenarchaeota
[15,16]. The broad phylogenetic distribution of FtsZ makes it an
ideal target to inhibit cell division in many different bacterial (and
euryarchaeal) species, and may allow the extension of this
technique to many previously uncultured and unknown organisms
present within environmental samples. Several chemicals have
been reported to block the function of FtsZ in various bacteria
including Mycobacterium tuberculosis, E. coli, and Staphylococcus aureus,
typically responding to treatment in filamentous, elongated
phenotypes [17,18,19,20,21,22,23,24,25,26]. Here we demon-
strate that compound PC190723 can be used to induce artificial
polyploidy in Bacillus subtilis ATCC 6633 [27]. We present data
indicating an increased cell size together with increased DNA
content for PC190723-treated cells. We have further demonstrat-
ed that single cell genomics after artificial polyploidy induction
results in less bias and greater genome coverage than with
untreated single cells, and helps improve de novo assembly, creating
larger and more contiguous sequences.
Results
B. subtilis Responded to Treatment with PC190723
Resulting in Larger Cells
We treated B. subtilis with PC190723 at early exponential phase
in liquid culture over different durations of time (see methods). To
measure its response to treatment, we used flow cytometry and
microscopy to determine changes in cell size when compared to
untreated control populations. Cytographic data from flow
cytometry showed that PC190723-treated cells became larger, as
measured by both side and forward scatter, during the course of
treatment compared to untreated control cells (Fig. 1A). The core
or mode of the cytographs represents the majority of the cell
population, often depicted in red. We put a crosshair at the core of
the control population (Fig. 1A Control) and applied the same
setting to the respective DMSO- and PC190723-treated samples
resulting in quantified cell distributions in quadrants, which was
used as indicators of cell size change (Fig. 1A, 1B). Cells in
quadrant two (Q2) are generally larger than the ones located in
other quadrants (see Methods for details). Briefly, B. subtilis treated
with PC190723 did not show any changes in cell size for the first
20 minutes. At 30 min after treatment, 5% of the treated
population showed an increase in cell size, 11% at 40 min, and
24% at 50 min. The change in Q2 plateaued at 60 minutes
onwards with an average change of around 40%, and about 80–
85% of cell particles located at Q2. When cells were treated with
DMSO alone, the solvent of PC190723, no change in cell size was
observed.
Exact change in cell size was measured via light microscopy
(Fig. 1C). Fifty PC190723-treated single cells and 26 control single
cells (sorted from the mode of each population) were analyzed
showing that the treated cells were 2–3 times longer than the
control cells (t-test p,0.0001; Fig. S1). This process also verified
that a single cell was deposited from the cell sorter, except for
a small portion of the control population. About 15% untreated
single particles and 10% PC190723-treated cells were actually
doublets butted together. Complete separation of such doublets
could not be achieved despite rigorous vortexing.
B. subtilis Treated with PC190723 Contained More DNA
Per Cell
In another cell preparation, we analyzed via flow cytometry ten
treatment and control preparations. We sorted 50 cells from the
core PC190723-treated and untreated control samples showing
the largest Q2 difference at 40-, 50-, and 60-min to estimate DNA
content per cell through qPCR assays. B. subtilis treated for 50
minutes yielded the highest amount of DNA content, although the
40- and 60-min treated cells also suggested polyploidy (Fig. 2).
Primer set A, which amplified a genomic region close to the
replication origin (Table S1), reported roughly 50% more DNA,
while primer set B, which amplified a region close to the
replication terminus, reported 75% more DNA in the 50-min
PC190723-treated cells than the untreated controls. Both treated
and controls show an elevated amount of DNA relative to the
expected amount (approximately 4.5 fg, as the average B. subtilis
genome size is 4.2 Mbp), which likely relates to stages in the
growth cycle. In a more replicated study, we further verified
elevated DNA content per cell in 50-min, PC190723-treated
B. subtilis versus untreated controls (Fig. S2).
PC190723-treated B. subtilis Cells Yielded Highest
Genomic Coverage with the Least Amplification Bias
DNA from single cells (N=14 PC190723-treated and N=18
untreated candidates from two 96-well PCR plates) was amplified
by MDA. Amplification bias for each amplicon was calculated
using the locus bias score (LBS) [28], which measures the variation
in amplification from MDA across the genome using six qPCR
primer pairs (Table S2; Materials and Methods – Determining
Maximum DNA Quantity Per Treatment Time). To determine
Figure 2. B. subtilis response to PC190723 treatment: Increased
DNA content. DNA content was assessed for PC190723 treated
(maximum effect from ten replicates) and control cells via six replicates
of 50 sorted cells for primer sets A (located near the origin) and B
(located near the terminus). Theta or multi-fork replication may account
for the discrepant reports from both primer sets. Cells treated for 50
minutes had more DNA content than the respective untreated controls.
Prolonged drug exposure may account for the reducing DNA content at
60-min treatment as related to DNA degradation. Error bars are 95% CI.
doi:10.1371/journal.pone.0037387.g002
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comparison studies, we selected the top two candidates having
the least theoretical amplification bias for each candidate from
plate one. Table 1 summarizes the results of the four selected,
sequenced candidates. The two PC190723-treated single cell
MDA samples used for sequencing had LBS scores of 2.00 and
2.64 (PC190723-A and –B, respectively) and two untreated single
cell samples had scores of 7.9 and 8.62 (untreated-A and –B,
respectively). All candidates’ sequencing data were normalized to
nearly 8.78610
6 raw reads and mapped to the B. subtilis ATCC
6633 genome (incomplete). PC190723-A had nearly 80.1%
genome coverage, while PC190723-B had 86.7%. Untreated-A
had 76.7% genome coverage, while untreated-B had 71.1%. On
average, there is about 9.5% more genomic coverage gained from
the PC190723-treated cells (Fig. 3A; best-fit line determined by
linear regression). Thus, increased genomic coverage translates to
reduced gaps in the mapped genome (Fig. 3B). The similar
placement of these gaps in the genome across all the four selected
candidates suggests amplification bias during the MDA process.
However, the presence of these gaps are reduced or eliminated at
that specific region in the genome from polyploid cells (Fig. 3B,
black circles). Across both plates, amplification bias is significantly
decreased in the PC190723-treated cells than in the control
samples (t-test of square root transformed data, N=31,
p=0.0087; Fig. S3).
PC190723-treated B. subtilis Cells Yielded Better Genome
Assemblies
Mapping raw reads, however, represents only cases in which
a reference genome is available. Consequently, we re-analyzed the
sequence data and performed de novo assemblies with 10 M raw
reads each. We found that PC190723-A and -B had 58.9% and
71.6% genome coverage, respectively, while untreated-A and -B
had 54.4% and 50.1% genome coverage, respectively (Table 1).
Thus, nearly 13% more genomic coverage is gained on average
when inhibiting cell division and performing de novo genome
assemblies (Fig. 4; best-fit line determined by linear regression).
Discussion
Single cell genomics is a great tool to study genomes of
‘unculturable’ bacterial species, although significant challenges
remain to be tackled before it becomes an efficient tool for broad
applications. Our results indicate that induced artificial polyploidy
will improve the performance of single cell genomics. It is already
known that adding more cells to an MDA reaction results in better
genome coverage [7]. Average locus representation in DNA
amplified from a single cell was shown to be approximately 30%,
and increased to near 80% with 10 cells as the starting
amplification template. Instead of adding more cells of the same
species, which one cannot do easily from a complex environmental
or human associated sample, we increased the copies of genomic
template within a single cell. This has achieved the same goal of
better genome coverage.
By inducing polyploidy, we have shown that the treated cells
have higher genomic recovery than the untreated cells, regardless
of whether the reads were either mapped to a reference genome
(Figs. 3A and 3B) or assembled de novo (Fig. 4). Both assemblies
suggest a trend between genomic coverage and LBS, though the
lack of significance is due to the sample size. Inducing polyploidy
allows for more even amplification across the genome (Fig. S3, S4),
while reducing gaps observed in the genome assemblies (Fig. 3B).
The similar placement of these gaps along the genome is likely due
to amplification bias. However, these gaps are greatly reduced in
the polyploid cells. The observed reduction of amplification bias in
the mapped genome of polyploid cells gives strong support for the
use of the LBS vetting technique as the polyploid MDA candidates
were selected for this study based on to their respective LBS
values.
We suggest that LBS correlates with genome coverage following
sequencing, whether using de novo assemblies or mapping reads to
a reference genome, though additional data may statistically
strengthen this claim. This technique allowed us to choose the best
among MDA products for later sequencing and provided support
for the superiority of the MDA products of the PC190723-treated
cells. The technique provides a means to vet samples before
committing to the expense of sequencing samples that could be
highly contaminated or would only produce very low coverage due
to extreme amplification bias. Because this method requires some
prior knowledge of a genome, it would not be useful for
sequencing single cells from a completely uncharacterized
community. Alternatively, other vetting procedures may be
employed which require less or no previous knowledge of genomic
content, such as shallow sequencing and identification of
conserved single copy genes [13], or verification that frequency
versus coverage histograms are normally distributed (i.e., no
particular region of the genome has been amplified much more
than another part).
The theoretical genome coverage with two to four copies of
chromosome should be beyond 90% (Fig. S5). However, our
selected polyploid candidates having an estimated two to three
chromosome copies yielded 83% mapped genome coverage, on
average. Various explanations may account for this less-than-
expected performance. First, MDA performance might be related
to the stage of chromosomal conditions, such as gene expression,
gene-regulator binding events, and sensitivity to nuclease activity.
Such chromosomal conditions in individual cells should generally
be more different than those of the multiple copies of chromo-
somes in the same cell. Therefore, the compensation advantage
among multiple-copy chromosomes in the same cell could be
reduced as they had the same accessibility to MDA. Second, the
chromosomal structure in dividing cells, particularly in the
induced polyploid cells, might be more compact than that of an
untreated, single copy cell [29]. Such compacted structure could,
for example, reduce polymerase binding due to restricted template
availability. Third, our experiment suggests that compound
PC190723 reduces survivability after a period of exposure during
growth (Fig. 2). PC190723 and other FtsZ inhibitors are initially
intended as options to antibiotics
[17,18,19,20,21,22,23,24,25,26,27], though we have demonstrat-
ed through PC190723 that such FtsZ inhibitors can alternatively
be used to improve genomic recovery from single cells. It is
possible that the DNA in some of the treated cells might begin to
degrade at the 50-min treatment time, which may explain the
observed decrease in DNA content after 60 minutes of exposure.
Fourth, compared to chromosomes from different single cells, the
multiple copy chromosomes from the same cell could be more
likely co-located together in the MDA process, thereby competing
for MDA reagents and resulting in less amplification.
During the progress of our work, a study was published
demonstrating that natural polyploidy helps genome assembly
[30]. Woyke and colleagues amplified DNA from a single bacterial
cell of Candidatus Sulcia muelleri DMIN that exhibits natural
polyploidy with hundreds of copies of its genome per cell. The
240 kb genome was completely finished with the amplified DNA
from a single cell, which is the first and only completely finished
single cell genome. In our experiment, the treated single cell has
four copies of the genome, at best, based on its doubling time.
Improving Genome Recovery via Induced Polyploidy
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between two and three copies of the genome. However, in this case
the control cell may be elevated artificially due to the occurrence
of doublets (i.e., incompletely divided cells that were sorted as
a single particle verified via microscopy), which may account for
the higher than theoretically possible DNA content per cell for
untreated cells of around 4–5 fg. Untreated cells were observed to
have a doublet rate of 15%, whereas PC190723-treated cells were
seen to have a doublet rate of around 10%. In addition, a portion
of the control cells having already replicated their chromosomes,
but have not yet divided, may also account for this discrepancy.
Our qPCR results (Fig. 2) show that we recover more DNA
content per treated cell than when using primer set A, while
primer set B reports significantly less. This observed difference in
yield may be due to theta replication, where two replication forks
are present in the chromosome (thus, forming a chromosomal
structure resembling h) starting at the replication origin, thereby
making more available priming sites for set A. Multi-fork
replication may also account for this observation, where a second
round of replication begins at the two oriC when the first
replication has yet to be completed. This opens, at least, four
Figure 3. PC190723-treated cells have increased genomic coverage and less amplification bias. (A) Genome coverage of mapped reads
increases with treatment. Also, LBS correlates with genome coverage (R
2=0.6998, p=0.1634). Best-fit line determined by least-squares linear
regression. (B) Mapped to B. subtilis ATCC 6633 genome, untreated control cells have more gaps (red lines) than inhibited cells. Similar gap placement
on the genome suggests amplification bias. Because of increased genomic template in polyploid cells, the number of gaps is greatly reduced (black
circles).
doi:10.1371/journal.pone.0037387.g003
Table 1. Summary of candidates selected for sequencing.
Candidates LBS
% coverage
(mapped)
a
% coverage
(de novo)
b
PC190723 -A 2.00 80.1 58.9
PC190723 -B 2.64 86.7 71.6
Control -A 7.90 76.7 54.4
Control -B 8.62 71.1 50.1
anormalized to nearly 8.78610
6 raw reads.
bnormalized to 1.0610
7 raw reads.
doi:10.1371/journal.pone.0037387.t001
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primer set B. Because we find more recovery with primer set A
over primer set B respective to the treated and untreated cells, it is
very possible that the cells sorted for this assay contained
chromosomes in mid-replication.
PC190723 is a known antimicrobial effective against Bacillus,
Staphylococcus, and probably against a range of other Gram-positive
bacteria [27]. This indicates that artificial polyploidy can be
applied to such broad Gram-positive bacteria that are important
players in the human microbiome as well as in natural and
agricultural [31,32,33] ecosystems. There are a number FtsZ
inhibitors available that are effective against Gram-negative or
phylogenetically diverse bacteria, which may broaden the appli-
cability of the approach demonstrated in this study [19]. As most
FtsZ inhibitors have a different spectrum in blocking bacterial cell
division, it is conceivable that a cocktail of inhibitors could be used
for a complex environmental sample.
To test the practicality of our method on an environmental
sample, we attempted to arrest cell division on a heterotrophic
desert consortium. Applying the same methods as described, but
using another FtsZ inhibitor, 3-MBA [17] dissolved in LB media,
our preliminary data based on cytographic evidence shows a visible
shift of the mode of the 3-MBA-treated population toward Q2,
with an average of 20% of the heterotrophs responding to
treatment (Fig. S6). Although additional studies are needed, this
evidence gives a promising outlook for the applicability of our
novel method on an environmental community.
It is possible to target other cell division machinery to create
artificial polyploidy, such as Min proteins. However, there are no
or less chemicals reported blocking functions of those targets than
FtsZ. Even some antibiotics that prohibit cell wall synthesis can be
tested for this application as well. With a limited study, we
observed an increase in cell length under treatment with
cephalexin at a low dose (data not show). Other researchers saw
the filament formation with other antibiotic treatment as well [34].
Further study is needed to verify if the observed longer cells
actually contain more DNA. A combination of these approaches
will likely fulfil the promise of artificial polyploidy.
One limitation of our method is that it requires growth of the
bacteria in the laboratory, however, it can be done in a community
setting, which will allow for the growth of more types of bacteria
than could be grown in isolation [35]. Another drawback may be
the different growth rates of environment bacteria, which may
make it difficult to determine when and for how long to treat
a sample. One other limitation is determining the ideal dosage of
other FtsZ inhibitors, as the commercial intent of these
compounds is an alternative form of antimicrobials to antibiotics.
These limitations are not insurmountable, however, and the net
benefit of our approach should be the availability of quality
genomic data that is not currently attainable through either
metagenomics or current SCG methods.
Materials and Methods
Blocking and Detecting Cell Division
PC190723 stock preparation. PC190723 (Cayman Chemi-
cal) was dissolved in 100% DMSO to 5 mg/ml and stored at
220uC.
B. subtilis preparation. Ten replicates of one B. subtilis
colony were inoculated in 2 ml no-glycerol LB broth (Teknova,
Hollister, CA) and incubated for 11 hr at 37uC while shaking at
200 rpm. Each stock culture was measured for OD600, diluted to
,0.05 OD600 in 20 ml LB broth contained in a 50 ml conical
Falcon
TM tube, and incubated as described earlier until reaching
,0.1 OD600 (approximately 60 min). Five milliters of each 20 ml
culture was immediately aliquoted into three 50 ml conical
Falcon
TM tubes, thereby representing one of three preparation
types: (1) Control – as is; (2) DMSO-treated control – addition of
1 ml 100% DMSO, and; (3) PC190723-treated – addition of 1 ml
PC190723 stock (1 mg PC190723 final). All preparations were
immediately incubated thereafter. Harvested cells were vortexed
thoroughly to separate the cells that still linked together after cell
division.
Determining maximum cell size and treatment
time. Three replicates of B. subtilis cultures were prepared as
previously described, but scaled up to 20 ml aliquots of the three
preparation types. One milliliter subsamples were taken at 10 min
intervals up to 120 min, stored on ice, vortexed for 5 min at
1,600 rpm, 10
5 data points were collected via flow cytometry (BD
Influx
TM, BD, Franklin Lakes, NJ), and analyzed for changes in
cell size using FlowJo ver. 8.8.6 (Tree Star, Inc., Ashland, OR).
Data near the origin were out-gated as they are most likely non-
viable cells and cell debris. The collected data were analyzed
under logarithmic scale of side scatter (SSC, y-axis) versus forward
scatter (FSC, x-axis), where crosshairs were set at the mode of each
control cytograph for every time point, thereby creating quadrants
and enumerating the relative percentage of cells occupying that
quadrant. Because both SSC and FSC are measurements of cell
size, it is, therefore, expected that the larger PC190723-treated
cells will shift in the direction of quadrant two (Q2) relative to its
non-treated control. The numerical value of change in Q2 (DQ2)
over time is then calculated by subtracting percent population
values in the control Q2 from the treated Q2. The differences
were plotted over time to determine the increase in cell size in
relation to treatment time. In our cell preparations involving ten
replications (not including the initial Determining Maximum Cell
Size Per Treatment Time study), the sample set having the median
DQ2 was selected for sorting cells intended for qPCR and MDA
assays.
Cell size was also measured using light microscopy. Cells were
sorted directly onto microscope slides from the mode of the
PC190723-treated and control populations. The samples were
heat fixed, stained with crystal violet for 1 min, washed with dI
water, and air-dried. Samples were viewed using a Zeiss Axiophot
light microscope (Carl Zeiss Inc. Oberkochen, Germany) at 4006.
Figure 4. Treated cells have better sequencing results. Genome
coverage following de novo genome assemblies similarly increases as
LBS decreases due to treatment with PC190723 (R
2=0.6033, p=0.2233).
Best-fit line determined by least-squares linear regression.
doi:10.1371/journal.pone.0037387.g004
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(Olympus Corporation, Center Valley, PA). Cells were measured
using Image Pro Plus ver. 6.2 (Media Cybernetics, Inc., Bethesda,
MD).
Determining maximum DNA quantity per treatment
time. To test if the maximum change in cell size at a particular
treatment time interval relates to maximum chromosome copy per
cell, qPCR assays of sorted cells were necessary to determine the
maximum DNA quantity. Ten replicates of B. subtilis cultures were
prepared and the subsequent FACS data analyzed for maximum
change in cell size as previously described. The PC190723-treated
replicate and its respective control showing the most change in cell
size at the 40-, 50-, and 60-min sampling intervals (Fig. 1B) were
selected for this assay. Fifty cells were sorted from the mode of
each population into 2 ml 40 mM Tris-HCl buffer pH=9 in a 96-
well PCR plate. DNA amount was determined using qPCR and
primer sets amplifying regions of the Bacillus genome near the
origin of replication and the replication terminus (Primer sets A
and B, respectively). Ten primer sets were designed using Primer
[36] (Table S2) and B. subtilis str. 168 genome (GenBank
NC000964), and validated with single cell qPCR assay. Six of
them were selected for sensitivity.
qPCR. The qPCR mastermix was prepared as per manufac-
turer’s protocol using the Power SYBRH Green PCR Master Mix
(Applied Biosystems, Carlsbad, CA). We used the 7500 Fast Dx
Real-Time PCR Instrument
TM (Applied Biosystems, Carlsbad,
CA) under the following cycling parameters for all primer sets:
One denaturation cycle of 95uC for 5 min, 45 amplification cycles
of 95uC for 10 sec, 45uC for 10 sec, and 72uC for 1 min; followed
by a melt curve analysis. Final concentrations for the following
qPCR mastermix reagents for each 25 ml were as follows: primer
mix (IDT, Coralville, IA) to 1 mM; BSA (NEB, Ipswich, MA) to
1.66; Power SYBRH Green PCR Master Mix (Applied Biosys-
tems, Carlsbad, CA) to 16. A standard curve was made from each
primer set using 1.0, 0.1, 0.01, 0.001, and 0.0001 ng B. subtilis
DNA extracted using the Ultra Clean Microbial DNA Kit (MoBio
Laboratories Inc, Carlsbad, CA).
Preparation for MDA and genomic analyses. Ten repli-
cates of B. subtilis cultures were prepared, but incubated for 50 min
at 37uC while shaking at 200 rpm, and the subsequent FACS data
analyzed as previously described. The 50-min treatment replicate
having the median DQ2 value from all ten preparations was
chosen for qPCR and MDA assays, and for subsequent genomic
analyses. Single cells from the mode of each population were
sorted into 2 ml lysis buffer in a 96-well PCR plate and the DNA
was amplified (See Whole Genome Amplification). The amplicons
from each MDA reaction were analyzed for genomic amplification
biases by calculating its respective locus bias score (LBS; See
Determining the Least Biased MDA Amplicon) [28]. Amplicons
with the lowest LBS from plate one of two were sequenced on the
IlluminaH GAIIx
TM sequencing platform.
Flow Cell Sorting
Cytometer preparation. FACS analysis and targeted cell
sorting were performed on the Influx
TM flow cytometer (BD,
Franklin Lakes, NJ) using a 488 nm laser at 22 psi at an average
rate of 4,000 counts per second (cps) with a 100 mm nozzle. To
greatly reduce the introduction of extraneous nucleic acid
material, particularly when sorting cells is scheduled, instrument
preparatory steps were performed. Prior to analysis and sorting,
the sheath and sample lines were flushed with 10% bleach for
30 min followed by sterile dI water and air-dried. The sheath tank
was thoroughly cleaned with 10% bleach and UV-exposed to
a 254 nm lamp overnight. Pre-sterilized sheath fluid (25 mM
HEPES with 100 mM sodium salt; BioSureH, Inc., Grass Valley,
CA) was loaded into the sterile sheath tank the following morning
and UV-exposed for over 60 min. The sheath fluid was filtered
through a 0.22 mm filter during all FACS analyses. The sort
chamber was cleaned with 10% bleach and 100% MeOH, where
appropriate.
Data collection. 10
5 data points per sample were collected
using Spigot ver. 6.1.9 (BD, Franklin Lakes, NJ) and analyzed
for increased changes in cell size under forward scatter (FSC)
versus side scatter (SSC) in logarithmic scale using FlowJo ver.
8.8.6 (Tree Star, Inc., Ashland, OR). Prior to sorting, calibration
procedures were followed as per manufacturer’s protocol. Of
importance, the Influx
TM was calibrated to deposit targeted cells
directly to the bottom center of each 96-well PCR reaction tube, as
verified by visual inspection.
Whole Genome Amplification
Contamination minimization. Because of the high likeli-
hood of untargeted amplification, strict preparatory steps were
followed to minimize nucleic acid contamination in the laboratory.
Summarily, all workspaces and equipment were cleaned with 10%
bleach solution. Glassware, disposables, reagents, tools, etc. were
autoclaved, stored in a PCR hood, and UV-exposed over 60 min.
Workers wore disposable lab coats, masks (covering nose and
mouth), and were double-gloved during all procedures. Two
HEPA filtration units (BlueAir 650 E; Chicago, IL) cycled the air
of our closed-door laboratory at least six times before any work
commenced. Air filtration remained in operation throughout
sorting and MDA procedures.
Lysis buffer preparation. Alkaline cell lysis buffer was
prepared and quality tested at least one day prior to our study
[37]. DI water was autoclaved (120uCa t,17 lb/in
2 for 60 min)
in a 50 ml CorningH jar, stored in a PCR hood, and UV-treated
for 60 min. The sterilized dI water was added to DTT (50 mM
final concentration; Acros Organics, Thermo Fisher Scientific,
Waltham, MA), which was pre-measured into sterile 50 ml conical
Falcon
TM tubes in a PCR hood, followed by the addition of 8 M
KOH (Hach Chemicals, Loveland, CO) to final concentration of
200 mM. The tube was sealed, vortexed, and the lysis buffer was
vacuum-filtered through a 0.22 mm screen. The lysis buffer was
stored at 4uC in foil. Lysis buffers stored longer than three weeks
were discarded.
Sorting cells for MDA. In the PCR hood, 2 ml of freshly
prepared lysis buffer was aliquoted into a 96-well PCR plate,
sealed with an adhesive plate seal, and briefly centrifuged. Only
the intended reaction wells were exposed during the sort process.
Immediately after cell sorting, the plate was resealed and
centrifuged for 30 sec at 1,300 g at 4uC. The reaction plate was
stored on ice until the next targeted sorting was performed.
Following sorting the plate was kept at 270uC for at least 60 min
to ensure proper lysis of sorted cells.
Multiple-strand displacement
amplification. Thermalcyclers were preheated to and main-
tained at 65uC. The 96-well PCR plate containing the lysed cells
was incubated at 65uC for 10 min to denature the DNA. This
modified alkaline lysis process with freezing and heating lysed both
treated and untreated B. subtilis cell equally well (Figure S7). The
96-well PCR plate was then centrifuged for 30 sec at 1,300 g at
4uC and immediately stored on ice thereafter. The MDA
mastermix and reaction plate steps were prepared in a PCR hood
at the following final concentrations to a 20 ml final volume, in
order: Autoclaved dI water; 106W29 reaction buffer (NEB) to 16;
500 mM random hexamers (Keck) to 5 mM; 10 mM dNTP mix
(Roche) to 1 mM; and 10 U W29 DNA polymerase (NEB) to
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and stored on ice until needed. Eighteen microliters were
aliquoted into each denatured sample, the plate immediately
sealed with an autoclaved 96-well rubber plate sealer, and
centrifuged for 30 sec at 1,300 g at 4uC. Genomic amplification
was performed at 30uC for 16 hr followed by W29 deactivation at
65uC for 10 min, and stored in 4uC. Amplification was visualized
via gel electrophoresis using 3 ml of each MDA product. MDA
positive controls included 1 ng B. subtilis extracted DNA, while
negative controls included dI water of the same volume.
Determining the least biased MDA amplification. To
identify DNA with the least amount of amplification bias, we
utilized the locus bias score (LBS) method. This method measures
change in representation of various location in a genome following
MDA as compared to an unamplified DNA control. Five
microliters of 1.5 kb sheared MDA fragments were used as
template (E210 Covaris, Woburn, MA). Six primer sets (A-F,
Table S2) were used to calculate the LBS for each MDA product
using qPCR. MDA negative controls were likewise sheared and
assayed to determine contamination levels during the MDA
process. No-template qPCR controls were also assayed to ensure
the absence of false amplification. MDA amplicons were
considered candidates for sequencing if all six primer sets showed
amplification of the correct product as verified by melt curve
analysis. Of the MDA candidates satisfying these criteria, two of
the MDA products having the lowest LBS value from plate one of
two were selected for genomic sequencing on the IlluminaH
GAIIx
TM platform.
DNA Sequencing and Analysis
The IlluminaH reads (69 nucleotides) were aligned by BWA [38]
with default parameters to Bacillus subtilis ATCC 6633 (GenBank
accession ADGS00000000) for each sample. The average depth of
coverage and percent genome recovery were calculated from
alignment results using perl scripts (available upon request). The
aligned results were piped to SAMtools ver 0.1.14 [39] for
conversion of BWA output format to BAM format and to perform
single nucleotide polymorphism (SNP) analysis. The above
analysis was also performed with normalized data by the fewest
reads.
The Velvetver. 1.1.02[40]assembler wasused toperform denovo
assembly,usingmultiplek-mersandtheassemblywithbestN50and
total contigs size was assembled with different coverage cut-off
thresholds.Theassemblywiththelargestcontigwasinitiallyselected
and the unique contigsfromall theotherassemblies werecombined
withthisinitialset.Thefractiongenomerecoveredbythisuniqueset
of contigs was calculated based on comparisons with the Bacillus
subtilis ATCC 6633 reference genome using MUMmer [41] (‘‘–
maxmatch’’ parameter).
Data Analysis
All data were analyzed and figures produced in R (v 2.13) [42].
T-tests and ANOVA were performed on data tested for normality
and equality of variance. The ANOVA analysis was performed
using the command ANOVA in package Car using type III sum of
squares [43]. ANOVA for analyzing DNA amounts per cell
(Figure 2) was based on the linear model (DNA content,Prepar-
ation+Treatment+Primer Set+Preparation:Treatment with prep-
aration as a random factor). An F-ratio or p-value is not reported
for Preparation as there is no exact solution available for the main
effect of a random variable in a three way ANOVA. The effect of
treatment for each primer set was calculated using planned
comparisons [44].
Supporting Information
Figure S1 Effect of PC190723 treatment on cells size.
PC190723 treated cells are significantly larger than untreated
control cells (t-test, p,0.0001). Error bars are 95% CI.
(TIF)
Figure S2 Increased DNA content in 50-min PC190723-
treated cells. In a more replicated study we verified that
PC190723-treated cells showed greater DNA content at 50
minutes of treatment. Here, we again started with ten populations,
but chose the treated population showing the median effect size for
qPCR analysis. Results with standard error are reported in Table
S1. In this case there are two separate preparations with six
replicate PC190723-treated and control 50-cell sorts for qPCR
using primer sets A and B. PC190723-treated cells showed almost
two and almost three times the amount of DNA compared to
control cells for primer sets A and B, respectively. Separate primer
sets are compared using planned comparisons within an ANOVA
framework (Table S1). Significance values for comparisons of
PC190723-treated and control for primers sets A and B are
p,0.001 and p=0.0125, respectively. Overall significance of the
treatment effect is also highly significant (p,0.001).
(TIF)
Figure S3 PC190723-treated cells have less amplifica-
tion bias. LBS results for PC190723-treated and control cells (14
and 18 data points, respectively) suggest that induced polyploidy
favors more even genome amplification and thus, less bias.
Seventeen samples were omitted from the analysis as one or more
primer sets showed either no amplification or amplification of
a product with a different melt curve. Error bars are standard
deviation. T-test of square root transformed data show treated and
control cells to be significantly different (p=0.0087).
(TIF)
Figure S4 PC190723-treated cells have reduced ampli-
fication bias and more even coverage than untreated
control cells.
(TIF)
Figure S5 Genome coverage increases and amplifica-
tion bias decreases as template cell number increases.
To address the possible relationships between template cell
number, genome coverage, and amplification bias, we sorted
replicates of E. coli ATCC 29425 in specific numbers for whole
genome amplification by MDA and calculated the amplification
bias via LBS. The two lowest LBS candidates from each cell
number were selected for genome sequencing and subsequent
genome assembly (mapped). This study shows that at an additional
20% of the genome is recovered when two templates are used in
MDA, compared to that of single cell templates. Having four to
eight templates reaches near-complete genomic recovery, and
plateus with additional template. Thus, having more than eight
starting genomic template will not yield additional genomic
information. Concurrent with increasing cell number is the decline
in amplification bias. We concluded from this study: (1) two copies
of chromosomal template will greatly increase genomic recovery,
compared to a single template; (2) four to eight template copies is
sufficient to obtain near-complete (if not, complete) genome
coverage, and; (3) amplification bias reduces with increasing
template number. Based on these findings, we expected polyploid
B. subtilis to yield at least 90% genomic coverage based on our
qPCR estimates of three chromosomes per cell. ‘‘AmpDNA’’ is
1 ng of purified E. coli ATCC 29425 DNA amplified via MDA.
‘‘unAmpDNA’’ is 10 mg of purified E. coli ATCC 29425 DNA
used for direct IlluminaH GAIIx library preparation. LBS was
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described.
(TIF)
Figure S6 Increased cell size in a heterogeneous com-
munity. Heterotrophs from a desert soil consortium were grown
in LB and treated with FtsZ inhibitor 3-MBA. After incubating for
120 min, 20% (averaged from two treatment replicates A and B) of
the population increased in size compared to the untreated
control. No response was observed in the LB-treated control. The
modes of each treated population shows a slight shift toward Q2.
This preliminary evidence demonstrates the promising applicabil-
ity of our method of arrested cytokinesis for the purpose of
improved genomic recovery from an environmental sample.
(TIF)
Figure S7 Lysis efficiency. To test the efficiency of our lysis
buffer and procedure, we treated B. subtilis with PC190723, as
described in Methods, incubated for 50 min after treatment, and
compared to untreated control grown for the same duration with
a lysis experiment. For comparison to treatment with lysis buffer,
the untreated control was also sorted into 2 ml sterile water.
Twenty cells from each condition were sorted into 2 ml of our lysis
buffer at six replicates each in a 96-well plate and had undergone
our standard procedure for cell lysis. The entire lysate volume was
transferred onto a microscope slide, air-dried, heat-fixed, and
simple-stained with crystal violet. Excess stain was gently washed
off with sterile dI water. In comparison to the lysis experiment and
for verification that cells were sorted into the plate, 20 cells from
each cell treatment were sorted directly onto a microscope slide
and stained as described above. Our microscopy analysis is based
on our direct observation for the presence of intact cells on the
microscope slide, thereby comparing the presence of intact
B. subtilis cells before and after lysis. After obtaining the average
number of observed cells across the six replicates for each
condition, we calculated ‘‘% lysis efficiency’’ as: % LE=100*(1 -
(# Avg. post-lysis cells/# Avg. pre-lysis cells), to take into account
for the possibility that some cells may have been washed off the
slide during the staining procedure.
(TIF)
Table S1 ANOVA for DNA content of PC190723-treated
and controls cells.
(DOC)
Table S2 Primer sets used for calculating LBS and DNA
amount.
(DOC)
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